Trial Results Summaries
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) strives to make the results of clinical trials available to the public in a standard, easy-to-read format. These summaries highlight ECOG-ACRIN studies, link to resources for more information, and acknowledge the vital contribution of trial participants to this research and improving patient care.
Below is the current listing of trial results summaries, with more to come as they are available. To read or download the results summary for a particular trial, click on the trial name.
Cancer Type | Trial Name | Trial ID | |||
Blood | Chemotherapy with or without Blinatumomab for B-Cell Acute Lymphoblastic Leukemia | E1910 | |||
Blood | Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia | E1912 | |||
Blood | Simplified Patient Care Strategy in Decreasing Early Death in Patients with Acute Promyelocytic Leukemia | EA9131 | |||
Breast | Value of Breast MRI to Treat Patients Diagnosed with Ductal Carcinoma In Situ | E4112 | |||
Breast | Reducing Chemotherapy-Induced Neuropathy in African American Patients with Breast Cancer | EAZ171 | |||
Breast | Trial Assigning Individualized Options for Treatment | TAILORx/PACCT-1 | |||
Head and Neck | Transoral Surgery and Low-Dose Radiation Therapy for Oropharynx Cancer | E3311 | |||
Kidney | Testing the Addition of the Drug Nivolumab Before and After Surgery for Renal Cell Cancer | PROSPER RCC/EA8143 | |||
Melanoma (Skin) | Testing the Therapy Sequence for Advanced BRAF Mutation Melanoma | DREAMseq/EA6134 |